| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3171 | 2016 |
| Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2625 | 2015 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1726* | 2020 |
| Hypermutation in pancreatic cancer JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ... Gastroenterology 152 (1), 68-74. e2, 2017 | 215 | 2017 |
| ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or … P Ghaneh, DH Palmer, S Cicconi, C Halloran, EE Psarelli, CL Rawcliffe, ... J Clin Oncol 38 (15_suppl), 4505, 2020 | 171 | 2020 |
| Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic … P Ghaneh, D Palmer, S Cicconi, R Jackson, CM Halloran, C Rawcliffe, ... The Lancet Gastroenterology & Hepatology 8 (2), 157-168, 2023 | 114 | 2023 |
| Targeting DNA damage response and replication stress in pancreatic cancer SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ... Gastroenterology 160 (1), 362-377. e13, 2021 | 107 | 2021 |
| The promises and pitfalls of epigenetic therapies in solid tumours JS Graham, SB Kaye, R Brown European journal of cancer 45 (7), 1129-1136, 2009 | 107 | 2009 |
| Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival W Dai, JM Teodoridis, C Zeller, J Graham, J Hersey, JM Flanagan, ... Clinical Cancer Research 17 (12), 4052-4062, 2011 | 103 | 2011 |
| Australian Pancreatic Cancer Genome I P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP …, 2016 | 95 | 2016 |
| HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer H Brunton, G Caligiuri, R Cunningham, R Upstill-Goddard, UM Bailey, ... Cell reports 31 (6), 2020 | 93 | 2020 |
| Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer R Sharma, J Graham, H Mitchell, A Brooks, S Blagden, H Gabra British journal of cancer 100 (5), 707-712, 2009 | 89 | 2009 |
| Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial MF Mulcahy, A Mahvash, M Pracht, AH Montazeri, S Bandula, RCG Martin, ... Journal of Clinical Oncology 39 (35), 3897-3907, 2021 | 84 | 2021 |
| Adjuvant therapy in colon cancer JS Graham, J Cassidy Expert review of anticancer therapy 12 (1), 99-109, 2012 | 71 | 2012 |
| Australian Pancreatic Cancer Genome Initiative Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 66 | 2015 |
| Imatinib in the Management of Multiple Gastrointestinal Stromal Tumors Associated With a Germline KIT K642E Mutation J Graham, M Debiec-Rychter, CL Corless, R Reid, R Davidson, JD White Archives of pathology & laboratory medicine 131 (9), 1393-1396, 2007 | 65 | 2007 |
| Evolving concepts in the management of drug resistant ovarian cancer: dose dense chemotherapy and the reversal of clinical platinum resistance DJ Pinato, J Graham, H Gabra, R Sharma Cancer treatment reviews 39 (2), 153-160, 2013 | 63 | 2013 |
| Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial N Joharatnam-Hogan, F Cafferty, R Hubner, D Swinson, S Sothi, K Gupta, ... The lancet Gastroenterology & hepatology 4 (11), 854-862, 2019 | 61 | 2019 |
| Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With … JF Seligmann, DJ Fisher, LC Brown, RA Adams, J Graham, P Quirke, ... Journal of Clinical Oncology 39 (33), 3705-3715, 2021 | 52 | 2021 |
| Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis RP Jones, SA Pugh, J Graham, JN Primrose, J Barriuso European Journal of Cancer 144, 368-381, 2021 | 41 | 2021 |
James PaulUniversity of GlasgowDirección de correo verificada de glasgow.ac.uk
